1. Home
  2. OI vs APLS Comparison

OI vs APLS Comparison

Compare OI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo O-I Glass Inc.

OI

O-I Glass Inc.

N/A

Current Price

$13.19

Market Cap

2.3B

ML Signal

N/A

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

N/A

Current Price

$21.75

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OI
APLS
Founded
1903
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
OI
APLS
Price
$13.19
$21.75
Analyst Decision
Buy
Buy
Analyst Count
7
20
Target Price
$17.29
$31.79
AVG Volume (30 Days)
1.6M
2.3M
Earning Date
05-13-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
112.50
EPS
N/A
0.20
Revenue
$6,426,000,000.00
$1,003,782,000.00
Revenue This Year
$3.21
N/A
Revenue Next Year
$1.82
$17.57
P/E Ratio
N/A
$107.10
Revenue Growth
N/A
28.46
52 Week Low
$9.23
$16.10
52 Week High
$16.91
$30.48

Technical Indicators

Market Signals
Indicator
OI
APLS
Relative Strength Index (RSI) 32.23 43.36
Support Level $12.49 $21.07
Resistance Level $13.54 $24.37
Average True Range (ATR) 0.58 1.02
MACD -0.29 -0.05
Stochastic Oscillator 16.89 41.23

Price Performance

Historical Comparison
OI
APLS

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: